These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15202517)

  • 21. Ethical implications of pharmacogenetics--do slippery slope arguments matter?
    Schubert L
    Bioethics; 2004 Aug; 18(4):361-78. PubMed ID: 15449407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of data privacy could hamper pharmacogenomics studies.
    Howard K
    Nat Rev Drug Discov; 2004 Sep; 3(9):725. PubMed ID: 15368651
    [No Abstract]   [Full Text] [Related]  

  • 23. The potential and limitations of personalized medicine in the doctor-patient relationship.
    Hapgood R
    Pharmacogenomics; 2003 Nov; 4(6):685-7. PubMed ID: 14596632
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?
    Davies SM
    Hematology Am Soc Hematol Educ Program; 2006; ():111-7. PubMed ID: 17124048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy.
    Phillips KA; Veenstra DL; Sadee W
    Health Serv Res; 2000 Dec; 35(5 Pt 3):128-40. PubMed ID: 16148957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why should we bother? Ethical and social issues in individualized medicine.
    Paul NW; Fangerau H
    Curr Drug Targets; 2006 Dec; 7(12):1721-7. PubMed ID: 17168846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethical considerations in clinical pharmacogenomics research.
    Issa AM
    Trends Pharmacol Sci; 2000 Jul; 21(7):247-9. PubMed ID: 10871892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethics and policy perspectives on personalized medicine in the post-genomic era.
    Landon MR
    J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical and public policy challenges for pharmacogenomics.
    Gershon ES; Alliey-Rodriguez N; Grennan K
    Dialogues Clin Neurosci; 2014 Dec; 16(4):567-74. PubMed ID: 25733960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics: questions and concerns.
    Mahlknecht U; Voelter-Mahlknecht S
    Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pharmacogenetics on medicine.
    Weber WW
    Environ Mol Mutagen; 2001; 37(3):179-84. PubMed ID: 11317335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics: ethical concerns for research and pharmacy practice.
    Alcalde MG; Rothstein MA
    Am J Health Syst Pharm; 2002 Nov; 59(22):2239-40. PubMed ID: 12455309
    [No Abstract]   [Full Text] [Related]  

  • 40. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.